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Abstract
Infection of macrophages with the protozoan parasite Toxoplasma gondii results in inhibition of a large panel of LPS-
responsive cytokines, including TNF-a, while leaving others such as IL-10 intact. Recent studies provide evidence that the
parasite interferes with chromatin remodeling at the TNF-a promoter that is normally associated with LPS stimulation, but
that is not required for TLR4 induction of IL-10. Here, we examined the effect of Toxoplasma on IL-10 induced by
simultaneous signaling through TLR4 and FccR, a combined stimulus that triggers histone H3 covalent modification at the
IL-10 promoter resulting in high level IL-10 cytokine production. We show that the parasite inhibits high level IL-10
production and prevents histone H3 Ser
10 phosphorylation and Lys
9/14 acetylation at the IL-10 promoter. These results
provide compelling evidence that T. gondii targets the host cell chromatin remodeling machinery to down-regulate
cytokine responses in infected macrophages.
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Introduction
The protozoan Toxoplasma gondii is an opportunistic apicomplexan
parasite with worldwide distribution in humans and animals. Although
normally causing an asymptomatic infection, the parasite can emerge
as a dangerous pathogen in immunodeficient hosts [1,2]. Previous
work by us and others has found that macrophages and dendritic cells,
important reservoirs of in vivo infection, become nonresponsive to
Toll-like receptor (TLR) and IFN-c receptor activation [3,4,5,6,7,8,9].
Thus, T. gondii-infected mouse bone marrow-derived macrophages
(BMMØ) are strongly inhibited in their ability to produce a large
battery of proinflammatory mediators during stimulation with TLR4
ligand lipopolysaccharide (LPS) [10]. Importantly, not all LPS-
responsive genes are suppressed by the parasite. In particular, TLR4
stimulation continues to elicit IL-10 production even when macro-
phages are infected with tachyzoites [10].
Recently, we conducted a detailed analysis of the activity of the
gene encoding TNF-a, a cytokine that is strongly suppressed by
Toxoplasma [11]. We found that transcription factors associated
with the TNF-a promoter, such as NFkB, cAMP-responsive
element-binding protein (CREB) and c-Jun, were activated and
translocated into the nucleus normally during LPS stimulation of
infected cells. Nevertheless, using chromatin immunoprecipitation
(ChIP), we obtained evidence that these factors were unable to
bind to their target sequences on the native TNF-a promoter after
parasite infection [11]. TLR4 triggering of BMMØ resulted in
Ser
10 phosphorylation and Lys
9/14 acetylation on histone H3 at
the TNF-a promoter, epigenetic changes associated with increased
transcriptional activity [12]. However, Toxoplasma infection
prevented these covalent modifications. When we examined the
IL-10 promoter, we found that the relatively low level of cytokine
produced during LPS stimulation occurred in the absence of
histone H3 modification, providing a possible explanation for the
lack of suppressive effect of the parasite on this particular cytokine.
Other studies havealsoindicated that LPS activation of macrophages
induces only low amounts of IL-10 and no significant modification of
histone H3 [13,14]. However, combining FccR ligation with TLR4
stimulation triggers high level IL-10 production, and this is associated
with ERK mitogen-activated protein kinase-dependent Ser
10 phos-
phorylation and Lys
9/14 acetylation of histone H3 on the IL-10
promoter. Based upon our findings at the TNF-a promoter [11], it was
our prediction that high level IL-10 synthesis stimulated by LPS and
immunecomplex(IC)wouldbesuppressedby theparasite,eventhough
low level LPS-induced IL-10 was not affected. Here, we tested this
prediction. We found that, as with the TNF-a promoter during LPS
stimulation, Toxoplasma blocked histone H3 covalent modification at the
IL-10 promoter during stimulation with LPS and IC. These combined
data provide strong support for a new model in which T. gondii targets
histone modification rather than the activity of specific transcription
factors, and in this way the parasite silences multiple host genes using a
common mechanism of suppression.
Results
Toxoplasma blocks high level IL-10 production
stimulated by combined LPS and immune complex
stimulation
We previously reported that Toxoplasma-infected BMMØ were
suppressed in their ability to produce TNF-a after LPS/TLR4
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by the parasite [11]. Here, we asked if high-level IL-10 induced by
LPS in combination with IC was blocked by the parasite. As
expected, stimulation with LPS alone induced low levels of IL-10,
and this response was not affected by T. gondii (Fig. 1A). However,
BMMØ produced approximately three-fold more IL-10 when the
cells were triggered with LPS + IC, although IC alone failed to
elicit this cytokine. Notably, this response was down modulated to
levels obtained with LPS alone when cells were pre-infected with
Toxoplasma (Fig. 1A).
We also measured IL-10 mRNA levels following stimulation
with the combination of LPS and IC. Previously, we found that the
parasite has no effect on increased IL-10 mRNA levels following
LPS stimulation [11]. Here, we found an approximately 10-fold
increase in IL-10 mRNA after stimulation with LPS + IC relative
to triggering with LPS alone (Fig. 1B). Infection of cells with
T. gondii resulted in suppressed IL-10 mRNA induction following
LPS + IC stimulation (Fig. 1B). We conclude that Toxoplasma does
not block low-level IL-10 induced by LPS, but that high level IL-
10 production triggered by the combination of LPS and IC is
sensitive to suppression by the parasite.
We examined the effect of LPS + IC on TNF-a levels in
BMMØ. In this case, FccR ligation did not further enhance TNF-
a production over levels obtained with LPS alone (Fig. 1C). Unlike
the case of IL-10, infection with T. gondii inhibited TNF-a
production during LPS and LPS + IC stimulation to background
levels.
T. gondii inhibits histone H3 covalent modification
triggered by LPS + IC
We next assessed if global changes in histone H3 during LPS +
IC stimulation were affected by Toxoplasma. We used Western blot
analysis to examine histone H3 Ser
10 phosphorylation following
stimulation of infected cells with LPS and LPS + IC. As reported
previously, LPS stimulation induced an increase in Ser
10
phosphorylation of histone H3 in total macrophage lysates, and
this response was inhibited when cells were preinfected with
Toxoplasma (Fig. 2A). In similar fashion, stimulation with LPS + IC
triggered increased Ser
10 histone H3 phosphorylation, and this
response was blocked by T. gondii (Fig. 2B). We also examined
histone H3 Lys
9/14 acetylation in cell lysates but found that
nonstimulated, noninfected BMMØ possessed constitutively high
levels of this histone modification that were not noticeably affected
by LPS + IC stimulation (data not shown).
Histone modifications detected in whole cell lysates are not
necessarily reflective of chromatin status at specific loci. Therefore,
we employed chromatin immunoprecipitation (ChIP) to evaluate
the effect of Toxoplasma on the status of IL-10 promoter-associated
histone H3, focusing on Ser
10 phosphorylation and Lys
9/14
acetylation in response to LPS + IC. Work by others has
established that IL-10 superinduced by combined stimulation with
LPS and IC results in chromatin remodeling, allowing access of
transcription factors at the IL-10 promoter [13,14]. We specifically
examined modification of histone H3 at the nucleosome 2 position
of the IL-10 promoter, since this region is most strongly associated
with histone phosphorylation and acetylation following stimulation
through TLR4 and FccR [14]. In accord with previous data,
stimulation of BMMØ with LPS alone failed to induce changes in
phosphorylation or acetylation of histone H3 at the IL-10
promoter (Fig. 3A and B). However, stimulation with LPS and
IC triggered rapid Ser
10 phosphorylation and Lys
9/14 acetylation,
and both of these responses were suppressed when cells were pre-
infected with Toxoplasma (Fig. 3A and B). We conclude that histone
H3 modification-independent IL-10 induction is not sensitive to
suppression by T. gondii, but that histone H3 modification-
dependent IL-10 synthesis, like control of TNF-a, is blocked by
infection.
Discussion
Superinduction of IL-10 in macrophages requires two signaling
cascades. One emanates from TLR4 and results in activation of
IL-10 transcription factors such as STAT3 and Sp1 [15]. The
second pathway is activated through FccR and results in
chromatin remodeling at the IL-10 promoter to allow access of
Figure 1. Toxoplasma inhibits superinduction of IL-10 stimulat-
ed by LPS and IC. Macrophages were infected with T. gondii and
18 hr later cells were stimulated with either LPS (10 ng/ml) or LPS plus
immune complex. 6 hr later supernatants were collected for IL-10 (A)
and TNF-a ELISA (C) and at the indicated time points cells were
harvested and RNA was extracted for real-time RT-PCR analysis of IL-10
mRNA levels relative to GAPDH (B). Error bars indicate SD of triplicate
samples. Each experiment was repeated a minimum of 3 times. In A and
B, * p,0.05 comparing IC+LPS to Tg+IC+LPS. In C, * p,0.05 comparing
LPS to Tg+LPS and IC+LPS to Tg+IC+LPS. Med, medium; Tg, T. gondii, IC,
immune complex.
doi:10.1371/journal.pone.0007589.g001
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Toxoplasma inhibits the superinduction response by interfering with
the chromatin remodeling pathway. These data reinforce recent
findings from our laboratory indicating that T. gondii has a similar
inhibitory effect on LPS-initiated histone H3 modification at the
TNF-a promoter [11]. In that case, we found that although
transcription factors were activated normally during LPS stimu-
lation, histone H3 phosphorylation and acetylation were blocked
by T. gondii. Recent studies have found that histone H3
phosphorylation, but not acetylation, is the proximal event to
IL-10 gene transcription [14]. Our finding that Toxoplasma
possesses inhibitory effects on total levels of histone H3 Ser
10
phosphorylation suggests that this may be the relevant target of
suppression.
The IL-10 molecule is an anti-inflammatory mediator that is
important in down-modulating proinflammatory responses to
avoid pathology. Its relevance during Toxoplasma infection was
shown in studies employing IL-10 gene deficient mice, because
animals infected with this parasite succumb during acute infection
in the absence of IL-10. Death is associated with a runaway
proinflammatory cytokine response that, despite controlling the
parasite, leads to lethal immunopathology during systemic and
oral infection [16,17]. Similarly, IL-10 has an important role in
limiting inflammation during toxoplasmic encephalitis [18]. From
the perspective of the parasite, IL-10 production is important to
keep the host alive to maximize chances of transmission.
Nevertheless, the ability of IL-10 to down-modulate activation of
innate immune effector cells such as macrophages suggests that
overproduction of this cytokine must be avoided. In this case,
uncontrolled parasite replication would rapidly lead to host death,
minimizing the chances of transmission to a new host. We
previously reported that low-level IL-10 induction triggered by
TLR4 was not inhibited by Toxoplasma. Here, we now demonstrate
that macrophages triggered through TLR4 and FccR produce
much higher amounts of IL-10, and that T. gondii blocks this
superinduction response to levels achieved by LPS stimulation
alone. We hypothesize that inhibition of high but not low level IL-
10 is a reflection of the parasite’s need to ensure appropriate
amounts of IL-10 that avoid immunopathology and permit cyst
formation, favoring long-term persistence in the host.
In addition to TNF-a and high level IL-10, many other LPS-
responsive cytokines and chemokines are down regulated by
Toxoplasma infection of macrophages [10]. Similar effects occur in
LPS-stimulated dendritic cells, where infection blocks upregulation
of MHC class II and costimulatory molecules in addition to TNF-
a and IL-12 [5]. It is also known that the parasite inhibits the
ability of macrophages and fibroblasts to respond to IFN-c [8,19].
For the case of fibroblasts, a large family of IFN-c-responsive genes
is inhibited during T. gondii infection [20]. The ability of the
parasite to simultaneously down-regulate large subsets of genes
during activation with stimuli such as LPS and IFN-c suggests that
targeting chromatin remodeling may be the mechanism that
mediates these profound effects.
The mechanism used by Toxoplasma to interfere with host
chromatin remodeling is presently unclear. The parasite is known
to inject rhoptry kinases and phosphatases into the host cytoplasm
during infection, and although these molecules relocate to the host
cell nucleus, whether they are involved in the effects reported here
is not presently known [21,22,23,24]. Nevertheless, it is possible
that such molecules interfere with host histone kinases and
Figure 2. Toxoplasma interferes with global Ser
10 phosphoryla-
tion of histone H3 induced by LPS and immune complex.
Macrophages were infected with tachyzoites (2:1 ratio of parasites to
cells), then 18 hr later cells were stimulated with LPS (10 ng/ml) (A) or
the combination of LPS and immune complex (B). Cells were lysed at
the indicated time points and lysates were subjected to Western blot
analysis using Ab specific for Ser
10 phosphorylated histone H3 and total
histone H3. Tg, T. gondii; IC, immune complex.
doi:10.1371/journal.pone.0007589.g002
Figure 3. T. gondii inhibits LPS + immune complex-inducible
histone H3 phosphorylation and acetylation at the IL-10
promoter. Macrophages were infected with tachyzoites at a parasite
to cell ratio of 2:1. After 18 hr incubation cells were subjected to
stimulation with LPS alone or LPS in combination with immune
complex. At either 30 min (A) or 60 min (B) cells were collected and
samples were subjected to ChIP analysis using anti-phospho-histone H3
(Ser
10) (A) or anti-acetyl-histone H3 (Lys
9/14) (B). Real-time PCR analysis
was carried out using primers specific for the IL-10 promoter. The data
were normalized to corresponding input controls. The error bars show
SD values for triplicate samples. This experiment is representative of
three performed. * p,0.05, comparing IC+LPS to Tg+IC+LPS. Med,
medium; Tg, T. gondii; IC, immune complex.
doi:10.1371/journal.pone.0007589.g003
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molecules directly dephosphorylate and deacetylate histone H3.
The findings reported in the present manuscript in combination
with other recent results from our laboratory together provide
strong evidence for a new view of Toxoplasma as an intracellular
pathogen that targets chromatin modification rather than (or in
addition to) targeting specific transcription factors. The finding
that proinflammatory TNF-a and anti-inflammatory IL-10
cytokines are both subject to the same type of regulation by
T. gondii reinforces the concept that interference with inducible
histone modification is a common strategy used by the parasite to
influence host gene transcription. These combined studies are the
first to demonstrate these effects during protozoan infection, but
recent data suggest that some bacterial pathogens, such as Shigella
flexneri, Listeria monocytogenes, and Mycobacterium tuberculosis adopt
similar strategies during infection [25,26,27,28]. Together, these
data support an emerging view of host cell chromatin structure as
an important target during microbial pathogenesis.
Materials and Methods
Ethics Statement
All work with animals received approval from the Cornell
University Institutional Animal Care and Use Committee.
Mice and Parasites
C57BL/6 mice (6–8 wk of age) were purchased from The
Jackson Laboratory. The mice were kept under specific pathogen-
free conditions at the Transgenic Mouse Facility, Cornell
University College of Veterinary Medicine. The facility is overseen
by an Institutional Animal Care and Use Committee. The Type I
T. gondii parasite strain RH was maintained by bi-weekly passage
on human foreskin fibroblast monolayers (American Type Tissue
Collection) in DMEM supplemented with 1% Bovine Growth
Serum (BGS), 100 U/ml penicillin and 0.1 mg/ml streptomycin.
Parasite cultures were tested every 6–8 wk using a PCR-based
ELISA (Roche Diagnostics).
Cell culture
Bone marrow cells were flushed from femur and tibia of
C57BL/6 mice and cultured in macrophage medium consisting of
DMEM supplemented with 10% BGS, 1 mM sodium pyruvate,
0.1 mM nonessential amino acids, 20% supernatant from L929
cells, 100 U/ml penicillin and 0.1 mg/ml streptomycin. The cells
were supplemented with fresh macrophage medium on Day 3
after culture initiation. After 5 days of culture, nonadherent cells
were removed, adherent monolayers were washed with PBS and
cells were harvested by gentle pipeting with ice-cold PBS.
Macrophage infection was accomplished by adding tachyzoites
to cell cultures followed by brief centrifugation (200 x g, 3 min) to
initiate contact between cells and parasites. Immune complex and
LPS were added 18 hr after infection. Cells were recovered at
varying times depending upon the assay performed.
Immune complex preparation
IgG-opsonized erythrocytes (E-IgG) were generated by incu-
bating sheep red blood cells (SRBC, Lampire Biological
Laboratories) with anti-SRBC IgG (MP Biomedicals) at non-
agglutinating titers for 30 min at room temperature while rotating.
Opsonized cells were washed once in Hank’s Buffered Saline
Solution (Invitrogen Life Technologies) and resuspended in
macrophage medium. E-IgG were added to cells at a ratio of 10
E-IgG to 1 macrophage.
Semiquantitative real-time PCR
RNA was isolated from cells using a commercial kit (RNeasy
Mini-kit; Qiagen) and cDNA synthesized according to standard
protocols. Real-time PCR was performed with a Power SYBR
green kit according to the manufacturer’s instructions (Applied
Biosystems). Amplification was carried out on an Applied
Biosystems 7700 Sequence Detector. The sequences of primers
used are indicated in Table 1.
Cytokine ELISA
IL-10 in culture supernatants was measured using a commercial
kit according to the manufacturer’s recommendations
(eBioscience).
Immunoblotting
Anti-phospho-histone H3 (Ser
10; Cell Signaling) and anti-total
histone H3 (Cell Signaling) were used for Western blot analysis.
Cells (2610
6/sample) were lysed in reducing SDS-PAGE sample
buffer, and DNA was sheared by forcing samples 3 times through
a 27-guage needle. After 3 min at 100uC, samples were separated
by 10% SDS-PAGE and proteins were subsequently electrotrans-
ferred onto nitrocellulose membranes. The membranes were
blocked in 0.1% Tween 20 in Tris-buffered saline, pH 7.6 (TBST)
containing 5% nonfat dry milk for 1 hr at room temperature,
followed by overnight incubation (4uC) with Ab in 5% BSA in
TBST. After washing blots in TBST, Ab binding was detected
with a horseradish peroxidase-conjugated secondary anti-rabbit
Ab (Jackson Immunoresearch) in TBST containing 5% nonfat dry
milk. Following 1 hr incubation, blots were washed in TBST and
developed with a chemiluminescence-based detection system (Cell
Signaling).
Chomatin immunoprecipitation (ChIP)
ChIP-grade Ab to phospho-histone H3 (Ser
10) and acetylated
histone H3 (Lys
9/14) were obtained from Cell Signaling. Assays
were performed using the ChIP-IT enzymatic express kit (Active
Motif) according to the manufacturer’s instructions. Briefly, cells
(1.5610
7/sample) were fixed in 1% paraformaldehyde at room
temperature for 10 min. Fixation was quenched by adding glycine
to the mixture. The cells were then collected by scraping in buffer
containing PMSF (100 mM). After brief centrifugation, the
macrophages were resuspended in cell digestion buffer (Active
Motif) and subjected to enzymatic digestion for 10 min at 37uC.
The reaction was terminated by addition of 0.5 M EDTA. Ab
were added to the sheared chromatin preparations and the
mixture was incubated with Protein G magnetic beads (Active
Motif) overnight at 4uC. The precipitated DNA-protein-Ab
complexes were then washed and the cross linking was reversed
by incubation at 65uC for 4 hr. Proteinase K was added to digest
Table 1. Primers used in this study.
Primer Sequence (59 to 39)
IL-10 forward CCT GGC TCA GCA CTG CTA T
IL-10 reverse GCT CTT ATT TTC ACA GGG GAG AA
GAPDH forward CCT GAA CAG AAC AGC AAT GGC T
GAPDH reverse GCT TGA CGG TGT CTT TTG CCT
IL-10 nucleosome 2 forward GCA GAA GTT CAT TCC GAC CA
IL-10 nucleosome 2 reverse GGC TCC TCC TCC CTC TTC TA
doi:10.1371/journal.pone.0007589.t001
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extraction, air dried, and redissolved in 100 mlH 20. The retrieved
DNA was then subjected to real-time RT-PCR using promoter-
specific primers.
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